APA (7th ed.) Citation

Wang, Y., Lv, H., Song, Y., Sang, D., Lv, Z., Ma, T., . . . Li, M. (2025). Low-dose vs standard-dose everolimus combined with endocrine therapy in patients with HR-positive, HER2-negative advanced breast cancer. Asian Journal of Surgery, 48(4), 2286. https://doi.org/10.1016/j.asjsur.2024.11.135

Chicago Style (17th ed.) Citation

Wang, Yichen, Huiyun Lv, Yuhua Song, Die Sang, Zheng Lv, Tianyi Ma, Ning Li, Chen Song, and Man Li. "Low-dose Vs Standard-dose Everolimus Combined with Endocrine Therapy in Patients with HR-positive, HER2-negative Advanced Breast Cancer." Asian Journal of Surgery 48, no. 4 (2025): 2286. https://doi.org/10.1016/j.asjsur.2024.11.135.

MLA (9th ed.) Citation

Wang, Yichen, et al. "Low-dose Vs Standard-dose Everolimus Combined with Endocrine Therapy in Patients with HR-positive, HER2-negative Advanced Breast Cancer." Asian Journal of Surgery, vol. 48, no. 4, 2025, p. 2286, https://doi.org/10.1016/j.asjsur.2024.11.135.